Search

In this paper, the Raman and difference FTIR spectra of NTO crystal, NTO solutions at different pH and saturated aqueous solution of Rb(NTO) x H2O have been studied. The determined structure of crystal suggests that the metal ion with oxygen and nitrogen atoms of [chemical structure see text] C-N, [chemical structure see text] C-NO2, [chemical structure see text] C=O and H2O formed bonds. The highest characterization peaks of Raman and FTIR spectra show that [chemical structure see text] C-NO2, [chemical structure see text] C=O and [chemical structure see text] C-N of NTO- formed week coordination bonds. The vibration spectra of saturation solution basically accord with those of the crystal. The bonds of saturation solution of the coordination compound have not changed. Therefore, the different vibration spectra of the saturation water solution of Rb (NTO) x H2O can be explicated by the formation of the bonds in crystal. The coordination compound formation mechanism of metal ion with NTO in alkali aqueous solution is discussed.

Two new cobalt phosphates, [Co(3)(pyz)(HPO(4))(2)F(2)] (1) and [Co(3)(4,4'-bpy)(HPO(4))(2)F(2)].xH(2)O (x approximately 0.7) (2), have been synthesized by hydrothermal methods in the presence of aromatic amines, and characterized by single-crystal X-ray diffraction and magnetic susceptibility. Their structures consist of neutral sheets of fluorinated cobalt phosphate which are pillared through pyrazine and 4,4'-bipyridine molecules to form 3D frameworks. The structures are related to that of the mineral lazulite. Both compounds show long-range antiferromagnetic ordering below 15 K and metamagnetic behaviors. Compound 1 reveals a two-step magnetic phase transition. Crystal data for 1: monoclinic, space group C2/c (No. 15), a = 21.809(4) A, b = 7.370(1) A, c = 7.395(1) A, beta = 103.753(3) degrees, and Z = 4. Crystal data for 2 are the same as those for 1 except a = 29.940(2) A, b = 7.4421(5) A, c = 7.4170(5) A, and beta = 93.444(1) degrees.

Two new layered transition metal oxalatophosphates, (H(3)TREN)[M(2)(HPO(4))(C(2)O(4))(2.5)].3H(2)O (M = Mn(II) and Fe(II)), have been synthesized by hydrothermal methods in the presence of a structure-directing organic amine, tris(2-aminoethyl)amine, and characterized by single-crystal X-ray diffraction and magnetic susceptibility. They are the first metal oxalatophosphates which adopt a two-dimensional honeycomb structure with the organic cations and water molecules intercalated in between. Within a layer, there are 12-membered pores made from 6 Mn, 1 phosphate, and 5 oxalate units. Measurements of field dependence of magnetization and variable-temperature susceptibilities under different fields were performed on a polycrystalline sample of the manganese compound. The results indicate a phase transition from a paramagnetic to an antiferromagnetic coupled state at about 12 K. Crystal data for the manganese compound follow: triclinic, space group Ponemacr; (No. 2), a = 8.8385(6) A, b = 9.0586(6) A, c = 16.020(1) A, alpha = 77.616(1) degrees, beta = 83.359(1) degrees, gamma = 68.251(1) degrees, and Z = 2. Crystal data for the iron compound are the same as those for the manganese compound except a = 8.7776(9) A, b = 8.9257(9) A, c = 15.884(2) A, alpha = 78.630(2) degrees, beta = 84.018(2) degrees, and gamma = 67.372(2) degrees.

Two fluorinated metal arsenates, (C(4)H(12)N(2))(1.5)[M(3)F(5)(HAsO(4))(2)(AsO(4))] (M = Fe, Ga), have been synthesized under hydrothermal conditions and characterized by single-crystal X-ray diffraction, magnetic susceptibility, Mössbauer spectroscopy, and (71)Ga NMR spectroscopy. The two compounds are isostructural and crystallize in the monoclinic space group P2(1)/c (No. 14) with a = 8.394(1) A, b = 21.992(3) A, c = 10.847(1) A, beta = 96.188(2) degrees, and Z = 4 for the Fe compound, and a = 8.398(1) A, b = 21.730(3) A, c = 10.679(1) A, beta = 95.318(2) degrees, and Z = 4 for the Ga compound. The structure consists of infinite chains of corner-sharing MX(6) (X = O, F) octahedra and dimers of edge-sharing MO(3)F(3) octahedra, which are linked into two-dimensional sheets through arsenate tetrahedra with diprotonated piperazinium cations between the sheets. Magnetic susceptibility and Mössbauer spectroscopy confirm the presence of Fe(III). The (71)Ga MAS NMR spectrum clearly shows a line shape consisting of three components, corresponding to three crystallographically distinct Ga sites.

Calcitonin gene-related peptide (CGRP) is a potent inhibitor of pancreatic enzyme secretion in vivo. Recent studies have shown that CGRP exerts its inhibitory action at a central vagal site. The present study investigates the mechanism responsible for the central action of CGRP. Rats were fitted with lateral cerebroventricular cannulas, using stereotaxic instruments, 4 days before pancreatic secretion studies. In anesthetized rats, administration of 2-deoxy-D-glucose (2-DG) (75 mg/kg iv) or CCK-8 (40 pmol. kg-1. h-1) produced a 100 and 75% increase in protein secretion, respectively, which was completely blocked by atropine. Intracerebroventricular (ICV) administration of CGRP (0.03-0.6 nmol/h) resulted in a dose-related inhibition of pancreatic protein secretion evoked by 2-DG or CCK-8. CGRP administered by the ICV route was 10-40 times more potent than CGRP given by the intravenous route. In contrast, ICV administration of CGRP had no significant effect on pancreatic protein secretion evoked by electrical vagal stimulation or bethanechol, which directly activates the pancreatic muscarinic receptor. Chemical sympathectomy induced by pretreatment with guanethedine (20 mg/kg ip, 2 days) or alpha-adrenergic receptor blockade with phentolamine did not alter the inhibitory effects of CGRP. We recently demonstrated that CCK stimulated the enteropancreatic neural pathways to mediate pancreatic secretion in rats with a chronic vagotomy. ICV-administered CGRP did not affect CCK-stimulated pancreatic secretion in rats with a chronic vagotomy. In conclusion, CGRP in the central nervous system inhibits pancreatic enzyme secretion stimulated by 2-DG and CCK-8, which act through vagal pathways. The inhibitory action of CGRP is not mediated by the sympathetic nervous system but appears to depend on intact vagus nerves.

The mutagenicity of domestic new drugs amrinone and milrinone were studied by Ames test, micronucleus test of mouse bone marrow and chromosome aberration assay in CHO cells. The results were as follows: neither amrinone nor milrinone was mutagenic in the Ames test; in chromosome aberration assay, both gave positive results; in mouse micronucleus test, amrinone gave a positive result when mice were exposed to 0.8 LD50 dose, but milrinone gave a negative result. These results suggested that amrinone and milrinone did not induce gene mutation, but amrinone induced chromosome damage both in vitro and in vivo, while the chromosome-damaging activity of milrinone in vitro may be minimized by biodetoxication in vivo.